Passive smoking associated with significant increases in the risk of nine health outcomes including lung and breast cancer

Troy Ignelzi hap­pened in­to the bio­phar­ma world. He had dropped his sole col­lege sci­ence course to go play rac­quet­ball with his then-girl­friend (now wife of

CStone has already secured sugemalimab’s approval in China for five cancer indications. Credit: Marko Aliaksandr/Shutterstock.com. The European Medicines Agency’s (EMA) Committee for Medicinal Products for

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes